D-Aspartic Acid by 5% Core — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

5 Capsule(s) Serving Size

30 Servings

Other Combinations Product Type

0% Evidence Coverage

Supplement Facts — Evidence Check

D-Aspartic Acid

3120 mg

📊 Market median: 2000.0mg (63 products)

Median 2000.0mg This product: 3120mg

3,3'-Diindolymethane

200 mg

Other Ingredients

Gelatin Microcrystalline Cellulose Silicon Dioxide Magnesium Stearate

Label Claims — Verification

❓ Nutrient

❓ All Other

❓ Structure/Function

All Other (97% of products) Structure/Function (94% of products) Nutrient (48% of products) No Claim (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions Take 5 capsules by mouth once daily with a meal.

⚠️ Warnings & Precautions

Warning Not intended for persons under the age of 18. Keep out of reach of children

Consult your health care professional prior to use if you have or suspect a medical condition, are taking prescription drugs or are pregnant or breast feeding.

California's Proposition 65 Warning Warning: Consuming this product can expose you to chemicals including lead, which is known to the state of California to cause birth defects or other reproductive harm. For more information go to: www.P65Warnings.ca.gov/food

This product was produced in a facility that may also process ingredients containing milk, egg, soy, shellfish, fish, tree nuts, wheat and peanuts.

🧪 Formulation Notes

D-Aspartic Acid 3,120mg with 200mg DIM per serving

Additional Information

Store in a cool, dry place away from sunlight & with lid securely tightened.

GMP Good Manufacturing Practice

Third Party Tested Product Guarantee

Product Details

UPC / SKU 8 50029 55521 6

DSLD Entry Date 2025-07-24

Product Type Other Combinations

Form Capsule

Brand 5% Core

DSLD ID 333956

Data Updated 2026-04-11

Research Evidence

9 Research Sources

37 Avg Quality Score

5 Rct

4 Other

C The Effects of Six-Gram D-Aspartic Acid Supplementation on the Testosterone, Cortisol, and Hematological Responses of Male Boxers Subjected to 11 Days of Nocturnal Exposure to Normobaric Hypoxia

Rct Nutrients 2023

PubMed DOI

C Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine

Rct Journal of psychopharmacology (Oxford, England) 2012

PubMed DOI

C The effects of d-aspartic acid supplementation in resistance-trained men over a three month training period: A randomised controlled trial

Rct PloS one 2017

PubMed DOI

C Short-Term d-Aspartic Acid Supplementation Does Not Affect Serum Biomarkers Associated With the Hypothalamic-Pituitary-Gonadal Axis in Male Climbers

Rct International journal of sport nutrition and exercise metabolism 2019

PubMed DOI

C Combined melatonin and adrenocorticotropic hormone treatment attenuates N-methyl-d-aspartate-induced infantile spasms in a rat model by regulating activation of the HPA axis

Other Neuroscience letters 2021

PubMed DOI

D A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain

Rct Anesthesia and analgesia 2004

PubMed DOI

D The efficacy of adrenocorticotropic hormone in a girl with anti-N-methyl-D-aspartate receptor encephalitis

Other Brain & development 2018

PubMed DOI

D The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats

Other Reproductive biology and endocrinology : RB&E 2009

PubMed DOI

F Blockage of N-methyl-D-aspartate receptors decreases testosterone levels and enhances postnatal neuronal apoptosis in the preoptic area of male rats

Other Neuroendocrinology 2000

PubMed

View all evidence for D Aspartic Acid →